Golumbeski George bought ABOS

June 3, 2026 · Form 4 insider transaction

Golumbeski George bought 35,500 shares of Acumen Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
35,500
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after35,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.

View the original Form 4 on SEC EDGAR